| 1. |
Sirover, M. A. (1997) Role of glycolytic protein, glyceraldehyde-3-phos-phate dehydrogenase, in normal cell function and in
cell pathology. J. Cell. Biochem.
66, 133–140.
<Occurrence Type="DOI"><Handle>10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.0.CO;2-R</Handle></Occurrence>
|
| |
| 2. |
Sirover, M. A. (1999) New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase.
Biochim. Biophys. Acta
1432, 159–184.
|
| |
| 3. |
Berry, M. D. and Boulton, A. A. (2000) Glyceraldehyde-3-phosphate dehydrogenase and apoptosis. J. Neurosci. Res.
60, 150–154.
<Occurrence Type="DOI"><Handle>10.1002/(SICI)1097-4547(20000415)60:2<150::AID-JNR3>3.0.CO;2-4</Handle></Occurrence>
|
| |
| 4. |
Tong, L., Toliver-Kinsky, T., Taglialatela, G., Werrbach-Perez, K., Wood, T., and Perez-Polo, J. R. (1998) Signal transduction
in neuronal death. J. Neurochem.
71, 447–459.
|
| |
| 5. |
Ito, Y., Pagano, P. J., Tornheim, K., Brecher, P., and Cohen, R. A. (1996) Oxidative stress increases glyceraldehyde-3-phosphate
dehydrogenase mRNA levels in isolated rabbit aorta. Am. J. Physiol.
270, H81–H87.
|
| |
| 6. |
Feldhaus, L. M. and Liedtke, A. J. (1998) mRNA expression of glycolytic enzymes and glucose transporter proteins in ischemic
myocardium with and without reperfusion. J. Mol. Cell Cardiol.
30, 2475–2485
|
| |
| 7. |
Graven, K. K. and Farber, H. W. (1998) Endothelial cell hypoxic stress proteins. J. Lab. Clin. Med.
132, 456–463.
<Occurrence Type="DOI"><Handle>10.1016/S0022-2143(98)90122-6</Handle></Occurrence>
|
| |
| 8. |
Edwards, Y. H., Clark, P., and Harros, H. (1976) Isozymes of glyceraldehyde-3-phosphate dehydrogenase in man and other mammals.
Ann. Hum. Genet.
40, 67–77.
|
| |
| 9. |
Soukri, A., Valverde, F., Hafid, N., Elkebbaj, M. S., and Serrano, A. (1995) Characterization of muscle glyceraldehyde-3-phosphate
dehydrogenase isoforms from euthermic and induced hibernating Jaculus orientalis. Biochim. Biophys. Acta
1243, 161–168.
|
| |
| 10. |
Saunders, P. A. Chen, R.-W., and Chuang, D.-M. (1999) Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms
during neuronal apoptosis. J. Neurochem. 72, pp925–932.
|
| |
| 11. |
Piechaczyk, M., Blancard, J. M., Riad-El Sabouty, S., Dani, C., Marty, L., and Jeanteur, P. (1984) Unusual abundance of vertebrate
3-phosphate dehydrogenase pseudogenes. Nature
312, 469–471.
|
| |
| 12. |
Allen, D. L., Linderman, J. K., Roy, R. R., et al. (1997) Apoptosis: a mechanism contributing to remodelling of skeletal muscle
in reponse to hindlimb unweighting. Am. J. Physiol.
273, C579–C587.
|
| |
| 13. |
Frerichs, K. U. and Hallenbeck, J. M. (1998) Hibernation in ground squirrels induces state and species-specific tolerance
to hypoxia and aglycemia: an in vitro study in hippocampal slices. J. Cereb. Blood Flow Metab.
18, 168–175.
|
| |
| 14. |
Drew, K. L., Zhou, F., Hu, Y., and Braddock, J. F. (2000) Microbial origin of glutamate in microdialysis studies of hibernating
ground squirrels. Soc. Neurosci. Abstr.
26, 188.2.
|
| |
| 15. |
Soukri, A., Valverde, F., Hafid, N., Elkebbaj, M. S., and Serrano, A. (1996) Occurrence of a differential expression of the
glyceraldehyde-3-phosphate dehydrogenase gene in muscle and liver from euthermic and induced hibernating jerboa. Gene
181, 139-145.
|
| |
| 16. |
Sunaga, K., Takahashi, H., Chuang, D.-M., and Ishitani, R. (1995) Glyceraldehyde-3-phosphate dehydrogenase is over-expressed
during apoptotic death of neuronal cultures and is recognised by a monoclonal antibody against amyloid plaques from Alzheimer’s
brain. Neurosci. Lett.
200, 133–136.
<Occurrence Type="DOI"><Handle>10.1016/0304-3940(95)12098-O</Handle></Occurrence>
|
| |
| 17. |
Ishitani, R., Sunaga, K., Hirano, A., Saunders, P., Katsube, N., and Chuang, D.-M. (1996) Evidence that glyceraldehyde-3-phosphate
dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J. Neurochem.
66, 928–935.
|
| |
| 18. |
Ishitani, R. and Chuang, D.-M. (1996) Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against
cytosine arabinoside-induced apoptosis in cultured cerebellar neurons. Proc. Natl. Acad. Sci. USA
93, 9937–9941.
|
| |
| 19. |
Zhang, D., Berry, M. D., Paterson, I. A., and Boulton, A. A. (1999) Two possible sites of action of R-2HMP: changes of mitochondrial
membrane potential and sub-cellular GAPDH protein. Soc. Neurosci. Abstr.
25, 606.18.
|
| |
| 20. |
Ishitani, R., Kimura, M., Sunaga, K., Katsube, N., Tanaka, M., and Chuang, D.-M. (1996) An antisense oligodeoxynucleotide
to glyceraldehyde-3-phos-phate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J. Pharmacol. Exp. Ther.
278, 447–454.
|
| |
| 21. |
Messmer, U. K. and Brune, B. (1996) Modification of macrophage glyceraldehyde-3-phosphate dehydrogenase in response to nitric
oxide. Eur. J. Pharmacol.
302, 171–182
<Occurrence Type="DOI"><Handle>10.1016/0014-2999(96)00055-6</Handle></Occurrence>
|
| |
| 22. |
Sawa, A., Kahn, A. A., Hester, L. D., and Snyder, S. H. (1997) Glyceraldeyde-3-phosphate dehydrogenase: nuclear translocation
participates in neuronal and nonneuronal cell death. Proc. Natl. Acad. Sci. USA
94, 11,669–11,674.
|
| |
| 23. |
Ishitani, R., Tanaka, M., Sunaga, K., Katsube, N., and Chuang, D.-M. (1998) Nuclear localization of overexpressed glyceraldehyde-3-phosphate
dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol. Pharmacol.
53, 701–707.
|
| |
| 24. |
Shashidharan, P., Chalmers-Redman, R. M. E., Carlile, G. W., et al. (1999) Nuclear translocation of G APDH-GFP fusion protein
during apoptosis. NeuroReport
10, 1149–1153.
|
| |
| 25. |
Saunders, P. A., Chalecka-Franaszek, E., and Chuang, D.-M. (1997) Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase
in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J. Neurochem.
69, 1820–1828.
|
| |
| 26. |
Schulze, H., Schuler, A., Stuber, D., Dobeli, H., Langen, H., and Huber, G. (1993) Rat brain glyceraldehyde-3-phosphate dehydrogenase
interacts with the recombinant cytoplasmic domain of Alzheimer’s β-amyloid precursor protein. J. Neurochem.
60, 1915–1922.
|
| |
| 27. |
Burke, J. R., Enghild, J. J., Martin, M. E., et al. (1996) Huntingtin and DRLPA proteins selectively interact with the enzyme
GAPDH. Nat. Med.
2, 347–350.
|
| |
| 28. |
Gentile, V., Sepe, C., Calvani, M., et al. (1998) Tissue transglutaminasecatalyzed formation of high-molecular-weight aggregates
in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. Arch. Biochem. Biophys.
352, 314–321.
|
| |
| 29. |
Koshy, B., Matilla, T., Burright, E. N., et al. (1996) Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene
products interact with glyc-eraldehyde-3-phosphate dehydrogenase. Hum. Mol. Genet.
5, 1311–1318.
|
| |
| 30. |
Koshy, B. and Zoghbi, H. Y. (1997) The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol.
7, 927–942.
|
| |
| 31. |
Tatton, N. A. (2000) Increased caspase 3 and bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis
in Parkinson’s disease. Exp. Neurol.
166, 29–43.
|
| |
| 32. |
Portera-Cailliau, C., Hedreen, J. C., Price, D. L., and Koliatsos, V. E. (1995) Evidence for apoptotic cell death in Huntington
disease and excitotoxic animal models. J. Neurosci.
15, 3775–3787
|
| |
| 33. |
Thomas, L. B., Gates, D. J., Richfield, E. K., O’Brien, T. F., S chweitzer, J. B., and Steindler, D. A. (1995) DNA end labelling
(TUNEL) in Huntington’s disease and other neuropathological conditions. Exp. Neurol.
133, 265–272.
|
| |
| 34. |
Dragunow, M., Faull, R. L. M., Lawlor, P., et al. (1995) In situ evidence for DNA fragmentation in Huntington’s disease striatum and Alzheimer’s disease temporal lobes. NeuroReport
6, 1053–1057.
|
| |
| 35. |
Lassmann, H., Bancher, C., Breitschopf, J., et al. (1995) Cell death in Alzheimer’s disease evaluated by DNA fragmentation
in situ. Acta Neuropathol.
89, 35–41.
|
| |
| 36. |
Paterson, I. A., Zhang, D., Warrington, R. C., and Boulton, A. A. (1998) R-Deprenyl and R-2-heptyl-N-methylpropargylamine
prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium. J. Neurochem.
70, 515–523.
|
| |
| 37. |
Berry, M. D. (1999) N8-acetyl spermidine protects rat cerebellar granule cells from low K+-induced apoptosis. J. Neurosci. Res.
55, 341–351.
<Occurrence Type="DOI"><Handle>10.1002/(SICI)1097-4547(19990201)55:3<341::AID-JNR9>3.0.CO;2-2</Handle></Occurrence>
|
| |
| 38. |
Leslie, R. and James, D. (1997) Antisense gene knockdown in the nervous system revisited: optimism for the future. Trends Neurol. Sci.
20, 321–322
<Occurrence Type="DOI"><Handle>10.1016/S0166-2236(97)01103-X</Handle></Occurrence>
|
| |
| 39. |
Berry, M._D. (1999) R-2HMP, an orally active agent combining independent anti-apoptotic and MAO-B inhibitory activities. CNS Drug Rev.
5, 105–124.
|
| |
| 40. |
Oberbauer, R. (1997) Not nonsense but antisense-applications of antisense oligonucleotides in different fields of medicine.
Wien. Klin. Wochen.
109, 40–46
|
| |
| 41. |
Ishitani, R., Tatton, N. A., Tsuchiya, K., Yamada, M., and Takahashi, H. (2000) Nuclear accumulation of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) in Machado-Joseph disease. Soc. Neurosci. Abstr.
26, 225.13.
|
| |
| 42. |
Kragten, E., Lalande, I., Zimmermann, K., et al. (1998) Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the
antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J. Biol. Chem.
273, 5821–5828.
|
| |
| 43. |
Carlile, G. W., Chalmers-Redman, R. M. E., Tatton, N. A., Pong, A., Borden, K. E., and Tatton, W. G. (2000) Reduced apoptosis
after nerve growth factor and serum withdrawl: conversion of tetrameric glyceraldehyde-3-phos-phate dehydrogenase to a dimer.
Mol. Pharmacol.t 57, 2–12.
|
| |
| 44. |
Zimmermann, K., Roggo, S., Kragten, E., Fürst, P., and Waldmeier, P. (1998) Synthesis of tools for target identification of
the anti-apoptotic compound CGP 3466; part I. Bioorg. Med. Chem. Lett.
8, 1195–1200.
<Occurrence Type="DOI"><Handle>10.1016/S0960-894X(98)00188-7</Handle></Occurrence>
|
| |
| 45. |
Marin, P., Maus, M., Bockaert, J., Glowinski, J., and Premont, J. (1995) Oxygen free radicals enhance the nitric oxide-induced
covalent NAD(+)-link-age to neuronal glyceraldehyde-3-phosphate dehydrogenase. Biochem. J.
309, 891–898.
|
| |
| 46. |
McDonald, L. J. and Moss, J. (1993) Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase.
Proc. Natl. Acad. Sci. USA
90, 6238–6241.
|
| |
| 47. |
Chen, R.-W., Saunders, P. A., Wei, H., Li, Z., Seth, P., and Chuang, D.-M. (1999) Involvement of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53. J. Neurosci.
19, 9654–9662.
|
| |
| 48. |
Goodman, Y., Bruce, A. J., Cheng, B., and Mattson, M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity,
oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem.
66, 1836–1844.
|
| |
| 49. |
Dubal, D. B., Shugrue, P. J., Wilson, M. E., Merchenthaler, I., and Wise, P. M. (1999) Estradiol modulates bcl-2 in cerebral
ischemia: a potential role for estrogen receptors. J. Neurosci.
19, 6385–6393.
|
| |
| 50. |
Joe, I., Zheng, J. B., and Ramirez, V. D. (2000) Specific effects of estrogen/ progesterone on glyceraldehyde-3-phosphate
dehydrogenase activity: sex differences and estrous cycle-dependent changes. Soc. Neurosci. Abstr.
26, 346.12.
|
| |